Shares of The Sherwin-Williams Company (NYSE:SHW – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the twenty brokerages that are currently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, five have issued a hold rating, twelve have assigned a buy rating and two have given a strong buy rating to the company. The average 1-year target price among brokers that have issued a report on the stock in the last year is $400.00.
SHW has been the subject of a number of analyst reports. Evercore ISI raised their price objective on shares of Sherwin-Williams from $400.00 to $420.00 and gave the company an “outperform” rating in a research note on Thursday, November 7th. JPMorgan Chase & Co. raised their price target on shares of Sherwin-Williams from $370.00 to $390.00 and gave the company an “overweight” rating in a research report on Monday, February 3rd. Royal Bank of Canada lowered their price objective on Sherwin-Williams from $438.00 to $415.00 and set an “outperform” rating on the stock in a research report on Monday, February 3rd. StockNews.com lowered Sherwin-Williams from a “buy” rating to a “hold” rating in a report on Thursday, November 28th. Finally, UBS Group reaffirmed an “underperform” rating on shares of Sherwin-Williams in a report on Friday, October 18th.
Read Our Latest Analysis on Sherwin-Williams
Insider Buying and Selling at Sherwin-Williams
Institutional Inflows and Outflows
Several hedge funds have recently bought and sold shares of SHW. Valued Wealth Advisors LLC lifted its holdings in shares of Sherwin-Williams by 88.9% in the third quarter. Valued Wealth Advisors LLC now owns 68 shares of the specialty chemicals company’s stock worth $26,000 after buying an additional 32 shares in the last quarter. Midwest Capital Advisors LLC bought a new stake in Sherwin-Williams in the 4th quarter valued at $26,000. First Personal Financial Services purchased a new stake in Sherwin-Williams in the 3rd quarter worth $29,000. FSA Wealth Management LLC bought a new position in shares of Sherwin-Williams during the 3rd quarter valued at about $32,000. Finally, GHP Investment Advisors Inc. grew its position in shares of Sherwin-Williams by 47.5% during the third quarter. GHP Investment Advisors Inc. now owns 87 shares of the specialty chemicals company’s stock valued at $33,000 after purchasing an additional 28 shares in the last quarter. Institutional investors own 77.67% of the company’s stock.
Sherwin-Williams Stock Performance
Sherwin-Williams stock opened at $360.74 on Monday. Sherwin-Williams has a twelve month low of $282.09 and a twelve month high of $400.42. The company has a quick ratio of 0.46, a current ratio of 0.79 and a debt-to-equity ratio of 2.02. The company has a market capitalization of $90.85 billion, a P/E ratio of 34.19, a PEG ratio of 2.86 and a beta of 1.22. The stock’s 50 day moving average is $356.87 and its 200 day moving average is $364.35.
Sherwin-Williams (NYSE:SHW – Get Free Report) last released its earnings results on Thursday, January 30th. The specialty chemicals company reported $2.09 EPS for the quarter, topping analysts’ consensus estimates of $2.07 by $0.02. Sherwin-Williams had a return on equity of 74.50% and a net margin of 11.61%. During the same period in the previous year, the company earned $1.81 EPS. On average, equities research analysts predict that Sherwin-Williams will post 12.12 earnings per share for the current fiscal year.
Sherwin-Williams Company Profile
The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.
Recommended Stories
- Five stocks we like better than Sherwin-Williams
- What is a Special Dividend?
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- Why Are These Companies Considered Blue Chips?
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- Top Biotech Stocks: Exploring Innovation Opportunities
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Receive News & Ratings for Sherwin-Williams Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sherwin-Williams and related companies with MarketBeat.com's FREE daily email newsletter.